Cube Dx hybcell technology

CAREERS

WE ARE CUBE!
FUN – HANDS ON – DYNAMIC

Talents are always welcome.

»HOMECOMPANY

Open Positions

Cube Dx provides an innovative, open-minded environment for people who want to achieve and contribute to common success.

We are currently looking for:

--

Apply!

Meet us

Meet us next...

...at the European Students Conference (www.esc-berlin.com) in Berlin. Cube Dx presents its Integrated Sepsis Diagnostics during a focussed industry exhibition and seminar on 29th of September, 2016. Make sure to be there. If you want to meet, make an appointment using info@cubedx.com!

News Ticker

Latest News...

We believe that the simultaneous (and parallel) measurement and evaluation of a set of biomarkers could improve the quality of clinical decisions of sepsis treatment. At ANESTHESIOLOGY® 2015, organised by the American Society of Anesthesiologists, a first study dealing with the quality of prognosis for single inflammatory and kidney markers in comparison to a combination of two of these markers was presented. The study was carried out by the Clinics of the Ludwig-Maximilians-University, Munich in collaboration with Clinic Neuperlach of the Municipal Hospital Munich.

The authors conclude that a combination of an inflammatory and a kidney biomarker leads to a significantly better prognosis than the use of single biomarkers, and can therefore more readily identify patients that are most critically affected by the disease. The authors recommend the simultaneous measurement of biomarkers to stratify a patient’s risk to die or of suffering critical kidney failure.